Literature DB >> 11559824

Alternative mechanisms of respiratory syncytial virus clearance in perforin knockout mice lead to enhanced disease.

S Aung1, J A Rutigliano, B S Graham.   

Abstract

Virus-specific cytotoxic T lymphocytes are key effectors for the clearance of virus-infected cells and are required for the normal clearance of respiratory syncytial virus (RSV) in mice. Although perforin/granzyme-mediated lysis of infected cells is thought to be the major molecular mechanism used by CD8(+) cytotoxic T lymphocytes for elimination of virus, its role in RSV has not been reported. Here, we show that viral clearance in perforin knockout (PKO) mice is slightly delayed but that both PKO and wild-type mice clear virus by day 10, suggesting an alternative mechanism of RSV clearance. Effector T cells from the lungs of both groups of mice were shown to lyse Fas (CD95)-overexpressing target cells in greater numbers than target cells expressing low levels of Fas, suggesting that Fas ligand (CD95L)-mediated target cell lysis was occurring in vivo. This cell lysis was associated with a delay in RSV-induced disease in PKO mice compared to the time of disease onset for wild-type controls, which correlated with increased and prolonged production of gamma interferon and tumor necrosis factor alpha levels in PKO mice. We conclude that while perforin is not necessary for the clearance of primary RSV infection, the use of alternative CTL target cell killing mechanisms is less efficient and can lead to enhanced disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11559824      PMCID: PMC114563          DOI: 10.1128/JVI.75.20.9918-9924.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  Overexpression of interleukin-4 delays virus clearance in mice infected with respiratory syncytial virus.

Authors:  J E Fischer; J E Johnson; R K Kuli-Zade; T R Johnson; S Aung; R A Parker; B S Graham
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

Review 2.  How do cytotoxic lymphocytes kill their targets?

Authors:  S Shresta; C T Pham; D A Thomas; T A Graubert; T J Ley
Journal:  Curr Opin Immunol       Date:  1998-10       Impact factor: 7.486

Review 3.  Immunological determinants of disease caused by respiratory syncytial virus.

Authors:  B S Graham
Journal:  Trends Microbiol       Date:  1996-07       Impact factor: 17.079

4.  CD8+ T cells clear influenza virus by perforin or Fas-dependent processes.

Authors:  D J Topham; R A Tripp; P C Doherty
Journal:  J Immunol       Date:  1997-12-01       Impact factor: 5.422

Review 5.  Fas and other cell death signaling pathways.

Authors:  V Depraetere; P Golstein
Journal:  Semin Immunol       Date:  1997-04       Impact factor: 11.130

6.  Fas-dependent CD4+ cytotoxic T-cell-mediated pathogenesis during virus infection.

Authors:  A J Zajac; D G Quinn; P L Cohen; J A Frelinger
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

7.  Characterization of early IL-12, IFN-alphabeta, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection.

Authors:  J S Orange; C A Biron
Journal:  J Immunol       Date:  1996-06-15       Impact factor: 5.422

Review 8.  Fas and FasL in the homeostatic regulation of immune responses.

Authors:  D H Lynch; F Ramsdell; M R Alderson
Journal:  Immunol Today       Date:  1995-12

9.  Protective Role of TNF-alpha in respiratory syncytial virus infection in vitro and in vivo.

Authors:  K M Neuzil; Y W Tang; B S Graham
Journal:  Am J Med Sci       Date:  1996-05       Impact factor: 2.378

10.  Perforin-deficient CD8+ T cells: in vivo priming and antigen-specific immunity against Listeria monocytogenes.

Authors:  D W White; A MacNeil; D H Busch; I M Pilip; E G Pamer; J T Harty
Journal:  J Immunol       Date:  1999-01-15       Impact factor: 5.422

View more
  30 in total

1.  Epitope-specific regulatory CD4 T cells reduce virus-induced illness while preserving CD8 T-cell effector function at the site of infection.

Authors:  Jie Liu; Tracy J Ruckwardt; Man Chen; John D Nicewonger; Teresa R Johnson; Barney S Graham
Journal:  J Virol       Date:  2010-08-04       Impact factor: 5.103

2.  Alpha and lambda interferon together mediate suppression of CD4 T cells induced by respiratory syncytial virus.

Authors:  Bo Chi; Harold L Dickensheets; Kirsten M Spann; Marc A Alston; Cindy Luongo; Laure Dumoutier; Jiaying Huang; Jean-Christophe Renauld; Sergei V Kotenko; Mario Roederer; Judy A Beeler; Raymond P Donnelly; Peter L Collins; Ronald L Rabin
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

3.  Regulation of cytokine production by virus-specific CD8 T cells in the lungs.

Authors:  Ross B Fulton; Matthew R Olson; Steven M Varga
Journal:  J Virol       Date:  2008-06-04       Impact factor: 5.103

4.  Respiratory syncytial virus load, viral dynamics, and disease severity in previously healthy naturally infected children.

Authors:  Chadi M El Saleeby; Andy J Bush; Lisa M Harrison; Jody A Aitken; John P Devincenzo
Journal:  J Infect Dis       Date:  2011-10-01       Impact factor: 5.226

5.  Perforin is a critical physiologic regulator of T-cell activation.

Authors:  Jennifer E Lykens; Catherine E Terrell; Erin E Zoller; Kimberly Risma; Michael B Jordan
Journal:  Blood       Date:  2011-05-23       Impact factor: 22.113

6.  Viral load drives disease in humans experimentally infected with respiratory syncytial virus.

Authors:  John P DeVincenzo; Tom Wilkinson; Akshay Vaishnaw; Jeff Cehelsky; Rachel Meyers; Saraswathy Nochur; Lisa Harrison; Patricia Meeking; Alex Mann; Elizabeth Moane; John Oxford; Rajat Pareek; Ryves Moore; Ed Walsh; Robert Studholme; Preston Dorsett; Rene Alvarez; Robert Lambkin-Williams
Journal:  Am J Respir Crit Care Med       Date:  2010-07-09       Impact factor: 21.405

Review 7.  Animal models of human respiratory syncytial virus disease.

Authors:  Reinout A Bem; Joseph B Domachowske; Helene F Rosenberg
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-05-13       Impact factor: 5.464

8.  Perforin and granzymes work in synergy to mediate cholangiocyte injury in experimental biliary atresia.

Authors:  Pranavkumar Shivakumar; Reena Mourya; Jorge A Bezerra
Journal:  J Hepatol       Date:  2013-10-02       Impact factor: 25.083

Review 9.  Human genetic factors and respiratory syncytial virus disease severity.

Authors:  Isao Miyairi; John P DeVincenzo
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

Review 10.  Understanding the mechanisms of viral induced asthma: new therapeutic directions.

Authors:  Nicole G Hansbro; Jay C Horvat; Peter A Wark; Philip M Hansbro
Journal:  Pharmacol Ther       Date:  2008-01-29       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.